source
- Sanofi reports shortages of Myozyme and Nexviazyme for Pompe disease after FDA manufacturing warningSanofi has warned that supplies of two medicines used to treat Pompe disease are running low. The company notified patient groups and physicians in the United States and Europe that the shortage af…
- Weekly roundup: Experts debate China biotech work ethic and a stalled megamergerThe Endpoints News team hosted a panel of industry experts in Cambridge, Massachusetts, to examine the future of biotech in China. Participants highlighted concerns about the country’s work ethic a…